<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03219099</url>
  </required_header>
  <id_info>
    <org_study_id>UKO-2017-1</org_study_id>
    <nct_id>NCT03219099</nct_id>
  </id_info>
  <brief_title>Normative Database for HR-pQCT-Based Radius and Tibia Strength</brief_title>
  <acronym>NODARATIS</acronym>
  <official_title>Population-Based Normative Database for HR-pQCT-Based Distal Radius and Tibia Strength Assessment in Switzerland</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Inselspital, Berne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Bern</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital Inselspital, Berne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A novel methodology was recently developed and validated by the applicants to compute bone&#xD;
      strength at the distal radius and tibia using second-generation HR-pQCT reconstructions. The&#xD;
      methodology is expected to improve significantly the assessment of bone fracture risk in&#xD;
      idiopathic and secondary osteoporosis, but no reference data and no reproducibility data are&#xD;
      available.&#xD;
&#xD;
      The objective of the study is the determination of the sex- and age-specific distributions of&#xD;
      accurate distal radius and tibia strength assessed by HR-pQCT in the Swiss population.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objective: De novo determination of sex- and age-specific reference intervals for vBMD, bone&#xD;
      architecture, and bone strength assessed by 3D HR-pQCT with a resolution of 61 µm (Xtreme CT&#xD;
      II, Scanco Medical, Brütisellen, Switzerland) in the Swiss population.&#xD;
&#xD;
      Design: Population-based, age- and sex-stratified, cross-sectional study in a single centre.&#xD;
&#xD;
      Study Size: For the main part, 480 valid data sets will be needed for two age reference&#xD;
      intervals for both women and men. The number of double/triple stack scans will be between 1&#xD;
      and 3 depending on graded motion artefacts.&#xD;
&#xD;
      Among the 120 participants of each reference interval, 21 will be needed to assess&#xD;
      reproducibility. For these volunteers, the number of double/triple stack scans will be equal&#xD;
      to 3.&#xD;
&#xD;
      Project Assessments, Procedures: participant demographics and physical activity will be&#xD;
      obtained and the validated Swiss FRAX questionnaire will be filled to determine the&#xD;
      epidemiology-based 10-year fracture risk. Grip strength will be measured. A DXA measurement&#xD;
      at the hip will be done according to the standard protocol of the Universitätspoliklinik für&#xD;
      Osteoporose. For participants at elevated vertebral fracture risk, lateral and&#xD;
      antero-posterior DXA of the spine will be added for vertebral fracture assessment (VFA) and&#xD;
      spine areal bone mineral density (aBMD). The HR-pQCT examination per se consists then of up&#xD;
      to 3 repeated double stack scans at the distal radius and triple stack scans at the distal&#xD;
      tibia.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">June 14, 2018</start_date>
  <completion_date type="Anticipated">May 2020</completion_date>
  <primary_completion_date type="Anticipated">May 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Bone strength at distal radius and tibia, assessed by HR-pQCT</measure>
    <time_frame>At baseline (cross-sectional, single timepoint for data collection)</time_frame>
    <description>Normative Database for HR-pQCT-Based Distal Radius and Tibia Strength in Swiss women and men</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>In-vivo reproducibility of radius strength calculations</measure>
    <time_frame>At baseline</time_frame>
    <description>3 repeated double/ triple stack scans, after reposition, data collection within 1 hour at one single time point</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>In-vivo reproducibility of tibia strength calculations</measure>
    <time_frame>At baseline</time_frame>
    <description>3 repeated double/ triple stack scans, after reposition, data collection within 1 hour at one single time point</description>
  </secondary_outcome>
  <enrollment type="Anticipated">576</enrollment>
  <condition>Osteoporosis</condition>
  <condition>Diagnoses Disease</condition>
  <condition>Fracture</condition>
  <condition>Bone Strength</condition>
  <eligibility>
    <study_pop>
      <textblock>
        The project population are female and male healthy volunteers above 20 years old. Following&#xD;
        international recommendations, the number of participants for the calculation of the&#xD;
        reference intervals is set to 576. Among these, the assessment of reproducibility of the&#xD;
        novel bone strength estimation methodology will be performed in 42 participants.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy volunteers aged 20 years or older living in Switzerland&#xD;
&#xD;
          -  Written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Psychological disorder or dementia in order to understand the informed consent and be&#xD;
             able to fill the FRAX questionnaire&#xD;
&#xD;
          -  Implant or a fracture at the DXA and HR-pQCT measurement sites&#xD;
&#xD;
          -  Inability to keep the extremities still for the few minutes of an HR-pQCT examination&#xD;
             (e.g. Parkinson disease or spastic syndrome)&#xD;
&#xD;
          -  History of low trauma fracture&#xD;
&#xD;
          -  Known pregnancy or lactating women&#xD;
&#xD;
          -  History of hysterectomy and/or ovariectomy&#xD;
&#xD;
          -  Known metabolic bone disorders, such as osteogenesis imperfecta, Paget's disease or&#xD;
             sclerosteosis (osteopenia or idiopathic osteoporosis are not exclusion criteria)&#xD;
&#xD;
          -  Ever use of one or more of the following bone active substances: bisphosphonates,&#xD;
             RANKL-inhibitors (DENOSUMAB), selective estrogen receptors (SERMS) or&#xD;
             parathormone/teriparatide&#xD;
&#xD;
          -  Ever use of oral glucocorticoids during more than 3 months or currently taking&#xD;
             glucocorticoids&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kurt Lippuner, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>Department of Osteoporosis, Bern University Hospital, University of Bern, CH-3010 Bern, Switzerland</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Philippe Zysset, Ph.D.</last_name>
    <role>Study Director</role>
    <affiliation>Institute of Surgical Technology and Biomechanics</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kurt Lippuner, M.D.</last_name>
    <phone>+41 31 632 31 28</phone>
    <email>kurt.lippuner@insel.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Anna Stuck, M.D.</last_name>
    <phone>+41 31 632 69 41</phone>
    <email>anna.stuck@insel.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital Inselspital</name>
      <address>
        <city>Bern</city>
        <zip>3010</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>October 2018</verification_date>
  <study_first_submitted>July 13, 2017</study_first_submitted>
  <study_first_submitted_qc>July 13, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 17, 2017</study_first_posted>
  <last_update_submitted>October 20, 2018</last_update_submitted>
  <last_update_submitted_qc>October 20, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoporosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

